CT regulation in India: Science or social justice?
Mark Barnes, JD, LLM Faculty Co-Director, Multi-Regional Clinical Trials Center at Harvard (Harvard MRCT), Lecturer, Harvard Law…
Author
MSF urges India to stand strong against attack on affordable medicines
Many governments and treatment providers rely on affordable quality generic medicines from India to treat life-threatening…
Celebrating 20 Years
1994-2014 Express Pharma Pulse to Express Pharma
As we mark Express Pharma’s 20th anniversary, experts retrospect on some of the…
India on the brink of an opportunity
On Express Pharma’s 20th Anniversary, Ranjana Smetacek, Director General, Organisation of Pharmaceutical Producers of India (OPPI)…
The biotechnology environment
The recent changes in the Government seems to have excited the industry but the real test will be to see if the enthusiasm…
Forging India’s bioeconomy
Without the support of its government, the Indian biotech industry may not be able to achieve its high potential, say James…
Wake up call for Indian pharma
Unless Indian pharma companies wake up to the new “patent challenge” regime, they could “miss the bus”, opines Dr Gopakumar G…
DRL launches docetaxel injection in US
Docetaxel injection USP, 20 mg/mL and 80 mg/4 mL are available as a single dose
Aurobindo Pharma to buy Natrol for $132.5 million
Emerges as the highest and best bidder to acquire the California-based company
Venus gets marketing authorisation for Meropenem
Meropenem is a last-resort drug of the carbapenem class of antibiotics which is used in intensive care units (ICUs) of hospitals